Non-infectious Intermediate, Posterior and Panuveitis

DrugDrug NameDrug Description
DB00051AdalimumabA monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
DrugDrug NameTargetType
DB00051AdalimumabTumor necrosis factortarget
DrugDrug NamePhaseStatusCount